Miller L J, Dong M, Harikumar K G, Gao F
Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA.
Biochem Soc Trans. 2007 Aug;35(Pt 4):709-12. doi: 10.1042/BST0350709.
The secretin receptor is prototypic of Class II GPCRs (G-protein-coupled receptors), based on its structural and functional characteristics and those of its natural agonist ligand. Secretin represents a linear 27-residue peptide with diffuse pharmacophoric domain. The secretin receptor includes the typical signature sequences for this receptor family within its predicted transmembrane segments and the highly conserved six cysteine residues contributing to three intradomain disulfide bonds within its long N-terminus. This domain is critical for secretin binding based on receptor mutagenesis and photoaffinity labelling studies. Full agonist analogues of secretin incorporating a photolabile moiety at various positions throughout the pharmacophore covalently label residues within this region, while only N-terminal probes have labelled the core helical bundle domain. Combining insights coming from receptor structural studies, peptide structure-activity relationship considerations, photoaffinity labelling, and application of fluorescence techniques has resulted in the development of a working model of the secretin-receptor complex. This supports the initial docking of the peptide agonist within a cleft in the receptor N-terminus, providing the opportunity for an endogenous sequence within that domain to interact with the core of the receptor. This interaction is believed to be key in the molecular basis of conformational change associated with activation of this receptor. The site of action of this endogenous agonist could also provide a possible target for small molecule agonists to act.
基于促胰液素受体及其天然激动剂配体的结构和功能特征,它是II类G蛋白偶联受体(GPCR)的原型。促胰液素是一种具有弥散药效基团的27个残基的线性肽。促胰液素受体在其预测的跨膜区段内包含该受体家族的典型特征序列,并且在其长N端有高度保守的六个半胱氨酸残基,形成三个结构域内二硫键。基于受体诱变和光亲和标记研究,该结构域对于促胰液素结合至关重要。在整个药效基团的各个位置掺入光不稳定部分的促胰液素的完全激动剂类似物共价标记该区域内的残基,而只有N端探针标记了核心螺旋束结构域。结合来自受体结构研究、肽结构-活性关系考量、光亲和标记以及荧光技术应用的见解,已形成了促胰液素-受体复合物的工作模型。这支持了肽激动剂在受体N端裂隙中的初始对接,为该结构域内的内源性序列与受体核心相互作用提供了机会。这种相互作用被认为是与该受体激活相关的构象变化分子基础的关键。这种内源性激动剂的作用位点也可能为小分子激动剂提供作用靶点。